Is it too late to buy this rising FTSE 250 defence star after its shares jump on Q1 update?

QinetiQ is a FTSE 250 high-tech firm that looks to me like it could be the next big thing in the UK defence sector, with its Q1 update bolstering my view.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Silhouette of a bull standing on top of a landscape with the sun setting behind it

Image source: Getty Images

FTSE 250 defence star QinetiQ (LSE: QQ) is near its all-time £4.80 high following its 18 July Q1 trading update.

This reaffirmed that it is on track to achieve its key performance targets from now to 2027.

From 2024-25, it expects to deliver high-single-digit organic revenue growth, at a stable operating profit margin. This is based on its £1.74bn order book (up from £1.72bn the previous year), 64% of which is under long-term contract.

For 2025-26, it expects to make about £2.4bn of organic revenue at a margin of around 12%.

The firm added that the £100m share buyback announced in its full-year 2024 results will be completed this financial year. At that time, it also announced an increase in its annual dividend to 8.25p (currently yielding 1.8%), from 7.7p.

Could the shares go higher?

It is a common misconception that shares that have risen sharply may have little or no value left in them.

This is not true. A company could simply be worth more than it was before. Or the markets might be in the process of catching up with that new valuation.

In fact, it could be that a firm is worth more than even its current share price implies. This is the case with QinetiQ, I think.

There are risks in the company, of course, as with all firms. A malfunctioning product could be very costly, given how expensive research and development is in this sector. Additionally, an extended period of peace, much as we want to see that, would probably hit demand for its products.

How much value is left in the stock?

On the key price-to-earnings ratio (P/E) of stock valuation measurement it trades at just 19.3. This is very cheap compared to the average 37.1 P/E of its peers.

The same applies to its price-to-book ratio (P/B) of 2.9 against a 4.7 peer group average. And it is also true of its 1.4 price-to-sales ratio (P/S) compared to its peers’ average of 1.7.

I used a discounted cash flow (DCF) analysis to ascertain how much of a bargain QinetiQ is in cash terms.

This shows it to be 40% undervalued at its current price of £4.67. So a fair value for the shares would be £7.78, although they may go lower or higher than that.

However, it confirms to me how much value is left in the stock, despite its price rise.

Will I buy the shares?

The sector in which QinetiQ operates looks set for major further expansion. The world has become an increasingly dangerous place since Russia invaded Georgia in 2008.

This is likely to continue as the war in Ukraine continues. China’s rhetoric over Taiwan remains an additional global security threat.

I also do not doubt that the firm will meet its strong growth targets. This should support further share price rises and increased dividends over time, I think.

For these reasons, I would buy QinetiQ today if I did not already have a holding in the defence sector, BAE Systems

Simon Watkins has positions in BAE Systems. The Motley Fool UK has recommended BAE Systems and QinetiQ Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »